EMA recommends suspension of 17-OHPC medicines in EU

The development comes after the regulator found increased cancer risk in people exposed to 17-OHPC.

Related Keywords

,Pharmacovigilance Risk Assessment Committee ,European Medicines Agency ,European Union ,Pharmaceutical Technology ,